Different Intervention Models of Premature Infants Based on the ICF Biopsychosocial Model
Launched by FEDERAL UNIVERSITY OF HEALTH SCIENCE OF PORTO ALEGRE · Aug 9, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different treatment approaches can help premature infants develop their motor skills and cognitive abilities. Premature babies, born before 37 weeks of pregnancy, often face challenges in their growth and development. The study aims to understand the effects of various interventions on these infants, using a framework that considers their physical, mental, and social well-being.
To participate in this trial, babies must be between 4 and 12 months old and have been born prematurely. They must also be patients at the UCS Clinical Center's High Risk Outpatient Clinic, and their parents or guardians need to give permission for them to join by signing a consent form. Participants can expect evaluations at the start and end of the study to track their progress. It's important to note that certain conditions, like severe neurological issues or specific congenital diseases, may exclude a baby from participating. Overall, this study aims to find effective ways to support the healthy development of premature infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Gestational age less than 37 weeks, corrected age between 4 and 12 months (one and a half month window) and at 24 months (four months window)
- • Babies from the High Risk Outpatient Clinic of the UCS Clinical Center, registered there;
- • Authorization of those responsible for the minor consenting to participation in the study by signing the Free and Informed Consent Form (TCLE).
- Exclusion Criteria:
- • All those subjects who do not follow the items mentioned above;
- • Presenting neurological diseases;
- • Presence of acute diseases (eg pneumonia, bronchiolitis, trauma)
- • Musculoskeletal alterations;
- • Genetic syndromes;
- • In genetic investigation;
- • Heart diseases with indication for surgical intervention;
- • Untreated congenital torticollis;
- • Congenital clubfoot;
- • Cerebral hemorrhage grade IV
- • Those who do not undergo the first and/or last evaluation;
- • Incomplete evaluation;
- • Convulsive crisis during study period;
- • Participants from other intervention programs.
About Federal University Of Health Science Of Porto Alegre
The Federal University of Health Science of Porto Alegre (UFCSPA) is a distinguished academic institution in Brazil, dedicated to advancing healthcare education, research, and clinical practice. Renowned for its commitment to excellence in medical and health sciences, UFCSPA plays a pivotal role in fostering innovation through rigorous clinical trials and collaborative research initiatives. The university's research programs are designed to address pressing health challenges, enhance patient care, and contribute to the scientific community, ensuring that findings translate into meaningful health solutions. With a multidisciplinary approach and a focus on ethical standards, UFCSPA is at the forefront of improving health outcomes both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto Alegre, Rs, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported